Rafael Bárcena Marugán-rekin lankidetzan egindako argitalpenak (15)

2015

  1. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2009

  1. Hepatitis C Virus Sensitivity to Combined Antiviral Therapy in Liver Transplant Versus Immunocompetent Patients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2195-2196

2008

  1. Severe Hepatitis C Recurrence: Is It a Negative Predictive Factor for Sustained Response to Treatment?

    Gastroenterology

2006

  1. De novo HBV infection caused by an anti-HBc positive donor in a vaccinated liver transplant recipient in spite of anti-HBs response [4]

    American Journal of Transplantation

  2. Hepatitis C Virus Recurrence After Liver Transplantation: Influence of Immunosuppressive Regimens on Viral Load and Liver Histology

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2499-2501

  3. Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose peg-interferon and ribavirin

    American Journal of Transplantation, Vol. 6, Núm. 10, pp. 2348-2355

  4. Improved graft function in liver-transplanted patients after partial splenic embolization: Reversal of splenic artery steal syndrome?

    Clinical Transplantation, Vol. 20, Núm. 4, pp. 517-523

  5. Scarce Influence of Corticosteroid Boluses on Long-Term Viral Load and Liver Histology in Transplanted Patients With Recurrent Hepatitis C

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2502-2504

2005

  1. HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin

    Journal of Hepatology, Vol. 43, Núm. 5, pp. 783-790

  2. Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?

    American Journal of Transplantation, Vol. 5, Núm. 11, pp. 2796-2798

  3. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin [1]

    Transplantation

  4. Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients

    Transplantation Proceedings

  5. Variability of MELD score during the year before liver transplantation

    Transplantation Proceedings

2003

  1. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: Preliminary results

    Transplantation Proceedings

  2. Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft

    Transplantation Proceedings